Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone

European Journal of Anaesthesiology

Volumn 26, Issue 11, 2009, Pages 946-953

  Rieg, Annette D ^a   Schroth, Sylvia C ^a   Grottke, Oliver ^a   Hein, Marc ^a   Ackermann, Diana ^a   Rossaint, Rolf ^a   Schälte, Gereon ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cardiotonic agents; Dobutamine; Hyperthermia; Hypothermia; Levosimendan; Milrinone; Ventricular trabeculae

Indexed keywords

DOBUTAMINE; LEVOSIMENDAN; MILRINONE; CALCIUM; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HYPOTHERMIA; INOTROPISM; NONHUMAN; TEMPERATURE SENSITIVITY; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; HEART CONTRACTION; IN VITRO STUDY; METABOLISM; RANDOMIZATION; TEMPERATURE;

ANIMALS; CALCIUM; CARDIOTONIC AGENTS; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; HYDRAZONES; HYPOTHERMIA; MILRINONE; MYOCARDIAL CONTRACTION; PYRIDAZINES; RANDOM ALLOCATION; TEMPERATURE;

EID: 74049134745     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328330e9a0     Document Type: Article

References (54)

1. Wu ST, Kojima S, Parmley WW, Wikman-Coffelt J. Relationship between cytosolic calcium and oxygen consumption in isolated rat hearts. Cell Calcium 1992; 13:235-247.
2. Opie LH, Coetzee WA, Dennis SC, et al. A potential role of calcium ions in early ischemic and reperfusion arrhythmias. Ann N Y Acad Sci 1988; 522:464-477.
3. Opie LH, Coetzee WA. Role of calcium ions in reperfusion arrhythmias: relevance to pharmacological interventions. Cardiovasc Drugs Ther 1988; 2:623-636.
4. 2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardium. Br J Pharmacol 2005; 145:1143-1152.
5. Haikala H, Kaivola J, Nissinen E, et al. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995; 27:1859-1866.
6. 2+ sensitivity of cardiac myofibrills and sarcoplasmatic reticulum in guinea pig. Circ Res 1995; 77:107-113.
7. Grandis DJ, MacGowan GA, Koretzky AP. Comparison of the effects of ORG 30029, dobutamine and high perfusate calcium on function and metabolism in rat heart. J Mol Cell Cardiol 1998; 30:2605-2612.
8. 2+]i in guinea-pig isolated ventricular myocytes. Eur J Pharmacol 1997; 339:97-100.
9. Haikala H, Nissinen E, Etemadzadeh E, et al. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995; 25:794-801.
10. 2+-transients in aequorin-loaded rightventricular papillary muscles and indo-l-loaded single ventricular cardiomyocytes of the rabbit. J Mol Cell Cardiol 1998; 30:1115-1128.
11. Missant C, Rex S, Segers P, Wouters PF. Levosimendan improves right ventricular coupling in a porcine model of right ventricular dysfunction. Crit Care Med 2007; 35:707-715.
12. Ukkonen H, Saraste M, Akkila J, et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000; 68:522-531.
13. Ukkonen H, Saraste M, Akkila J, et al. Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers. Clin Pharmacol Ther 1997; 61:596-607.
14. +channel in rat arterial myocytes. Eur J Pharmacol 1997; 333:249-259.
15. + ATP-channels. Anesth Analg 2000; 90:5-11.
16. Kopustinskiene DM, Pollesello P, Saris NE. Potassium-specific effects of levosimendan on heart mitochondria. Biochem Pharmacol 2004; 68:807-812.
17. Papp Z, Csapo K, Pollesello P, et al. Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovasc Drug Rev 2005; 23:71-98.
18. De Witt BJ, Ibrahim IN, Bayer E, et al. An analysis of responses to levosimendan in the pulmonary vascular bed of the cat. Anesth Analg 2002; 94:1427-1433.
19. Figgitt DP, Gillies PS, Goa KL. Levosimendan. Drugs 2001; 61:613-627.
20. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure [the LIDO study]: a randomised double-blind trial. Lancet 2002; 360:196-202.
21. Noto A, Giacomini M, Palandi A, et al. Levosimendan in septic cardial failure. Int Care Med 2005; 31:164-165.
22. Barraud D, Faivre V, Damy T, et al. Levosimendan restores both systolic and diastolic cardiac peformance in lipopolysaccharide-treated rabbits: Comparison with dobutamine and milrinone. Crit Care Med 2007; 35:1376-1382.
23. Tavernier B, Li JM, El-Omar MM, et al. Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats. FASEB J 2001; 15:294-296.
24. 2+-sensitivity but normal mitochondrial function in septic heart. Am J Respir Crit Care Med 2001; 163:362-367.
25. Riishede L, Nielsen-Kudsk F. Myocardial effects of adrenaline, isoprenaline and dobutamine at hypothermic conditions. Pharmacol Toxicol 1990; 66:354-360.
26. Oung CM, English M, Chiu RC, Hinchey EJ. Effects of hypothermia on hemodynamic responses to dopamine and dobutamine. J Trauma 1992; 33:671-678.
27. 2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition. Basic Clin Pharmacol Toxicol 2006; 98:74-78.
28. Mulieri L, Hasenfuss G, Ittleman F, et al. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res 1989; 65:1441-1444.
29. Kaheinen P, Pollesello P, Levijoiki J, Haikala H. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart. J Cardiovasc Pharmacol 2004; 43:555-561.
30. Usta C, Puddu PE, Papalia U, et al. Comparison of the inotropic effects of levosimendan, roliprame, and dobutamine on human atrial trabeculae. J Cardiovasc Pharmacol 2004; 44:622-625.
31. Saeki A, Goto Y, Hata K, et al. Negative inotropism of hyperthermia increases oxygen cost of contractility in canine hearts. Am J Physiol Heart Circ Physiol 2000; 279:2855-2864.
32. Melnikov A, Lokebo J, Lathrop D, Helgesen K. Alteration of the cardiac effects of isoproterenol and propanolol by hypothermia in isolated rat atrium. Gen Pharmacol 1996; 27:665-668. (Pubitemid 26233339)
33. Langendorff O. About the influence of hyperthermia and hypothermia to the hearts of warm-blooded animals. Pflügers Arch 1897; 66:355-400.
34. Weisser J, Martin J, Bisping E, et al. Influence of mild hypothermia on myocardial contractility and circulatory function. Basic Res Cardiol 2001; 96:198-205.
35. Liu B, Wohlfahrt B, Johansson BW. Effect of low temperature on contraction; on papillary muscle from rabbit, rat and hedgehog. Cryobiology 1990; 27:539-546.
36. 2+-transients in cardiac Purkinje fibers. Am J Physiol 1994; 36:725-733.
37. Sprung J, Laszlo A, Turner LA, et al. Effects of hypothermia, potassium, and verapamil on the action potential characteristics of canine cardiac Purkinje fibers. Anesthesiology 1995; 82:713-722.
38. 2+-sensitivity of cardiac myofibrils: a comparison of trout with mammals. Am J Physiol 1994; 267:62-70.
39. Harrison SM, Bers DM. Influence of temperature on the calcium sensitivity of myofilaments of skinned ventricular muscle from the rabbit. J Gen Physiol 1989; 93:411-428.
40. 2+] activated force. Am J Physiol Heart Circ Physiol 1991; 261:1005-1010.
41. 2+-ions in development of hypothermia associated inotropic effect in warm-blooded myocard. Pflügers Arch 1965; 285:1-18.
42. 2+] sensitivity by moderate hypothermia in guinea pig isolated hearts. Am J Physiol Heart Circ Physiol 1999; 277:2321-2332.
43. Fabiato A, Fabioto F. Effect of pH on the myofilaments and the sarcoplasmatic reticulum of skinned cells from cardiac and skeletal muscle. J Physiol 1978; 276:233-235.
44. Chapman RA. Sodium/calcium exchange and intracellular calcium buffering in ferret myocardium: an ion-selective microelectrode study. J Physiol (Lond) 1986; 373:163-179.
45. Sys SU, Goenen MJ, Chalant CH, Brutsaert DL. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle. Circulation 1986; 73:25-35.
46. Lochner A, Colesky F, Genade S. Effect of a calcium-sensitizing agent, levosimendan, on the postcardioplegic inotropic response of the myocardium. Cardiovasc Drugs Ther 2000; 14:271-281.
47. Nijhawan N, Nicolosi A, Montgomery M, et al. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharm 1999; 34:219-228.
48. Endoh M, Yanagtsawa T, Taira N, Blinks J. Effects of new inotropic agents on cyclic nucleotide and calcium transients in canine ventricular muscle. Circulation 1986; 73 (3 Pt 2):III117-III133.
49. Auffermann W, Stefenelli T, Shao T, et al. Influence of positive inotropic agents on intracellular calcium transients. Part I. Normal rat heart. Am Heart J 1989; 118:1219-1227. (Pubitemid 20014646)
50. Haikala H, Kaheinen P, Levijoki J, Linden IB. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer levosimendan. Cardiovasc Res 1997; 34:536-546.
51. Jonsson EN, Antila S, McFadyen L, et al. Population pharmacokinetics of levosimendan in patients with congestive heart failure. Br J Clin Pharmacol 2003; 55:544-551.
52. McGough MF, Pagel PS, Lowe D, et al. Effects of levosimendan on left ventricular function: correlation with plasma concentrations in conscious dogs. J Cardiothorac Vasc Anesth 1997; 11:49-53. (Pubitemid 27114208)
53. 2+-sensitivity of contractile elements in intact ferret myocardium. Am J Physiol Heart Circ Physiol 1998; 274:147-154.
54. Yokoshiki H, Katsube Y, Sunagawa M, et al. The novel calcium sensitzer levosimendan activates the ATP-sensitive potassium channel in rat ventricular cells. J Pharmacol Exp Ther 1997; 283:375-383.